LIU ET AL.
reaction mixture was quenched with H2O and extracted with CHCl3.
7
17
14
1
5
HO
The CHCl3 extract was then purified by silica gel CC to afford alcohols 6
(4.0 mg) and 7 (4.4 mg).
O
O
7'
3
8'
Alcohol 6. Colorless oil; Yield 89%; ½aꢃ 20 = ꢀ2.0 (CHCl3, c 0.20); ESIMS:
1'
18'
15'
6'
OH
HO 2'
D
m/z = 639.4 ([2M+ Na]+); 1H NMR (CDCl3, 300 MHz): d = 0.93 (3H, t,
J = 6.6 Hz, Me-17), 1.32ꢀ1.44 (12H, m), 1.54ꢀ1.60 (4H, m, H2-13, H2-15),
2.54 (2H, t, J=7.5Hz, H2-7), 3.59 (1H, m, H-14), 3.78 (6H, s, OMe-1, OMe-3),
6.30 (1H, d, J=2.1Hz, H-2), 6.34 (2H, d, J=2.1Hz, H-4, H-6).
R
4'
OH
1 R = OAc
2 R = OH
3 R = H
Alcohol 7. Colorless oil; Yield 89%; ½aꢃ 20 = +2.0 (CHCl3, c 0.20); ESIMS:
D
7'
m/z = 361.2 ([M + Na]+); 1H NMR (CDCl3, 300MHz): d =0.92 (3H, t, J=6.6Hz,
Me-18), 1.25ꢀ1.42 (12H, m), 1.54ꢀ1.59 (2H, m, H2-16), 1.72 (2H, m, H2-14),
2.64 (2H, t, J=7.8Hz, H2-8), 3.59 (1H, m, H-15), 3.80 (3H, s, OMe-4), 3.83
(3H, s, OMe-2), 4.66 (2H, s, H2-7), 6.33 (2H, s, H-3, H-5).
CH2OH
8'
6'
15'
MeO
HO
2'
S
OH
4'
OMe
4
8
2-Methoxy-2-phenyl-2-(trifluoromethyl)acetic acid (MTPA)
esters of 6
14
1
5
The (S)-MTPA ester was obtained by treating 6 (2.0 mg) with (R)-MTPA
chloride in dry pyridine for approximately 16h under stirring at room
temperature. The reaction mixture was purified by silica gel CC to afford
pure (S)-MTPA ester (6S, 3.2 mg). The same procedure was adopted for
the preparation of the (R)-MTPA ester (6R, 3.0 mg) using (S)-MTPA
chloride.
(S)-MTPA ester (6S). Colorless oil; Yield 89%; ESIMS: m/z = 547.3
([M + Na]+); 1H NMR (CDCl3, 300 MHz): d = 0.92 (3H, t, J = 7.2 Hz,
Me-17), 1.15 (2H, m, H2-12), 1.22 (2H, m, H2-9), 1.25 (4H, m, H2-10,
H2-11), 1.32 (2H, m, H2-16), 1.54 (2H, m, H2-13), 1.56 (3H, m, H2-8,
Ha-15), 1.65 (1H, m, Hb-15), 2.53 (2H, t, J = 7.5 Hz, H2-7), 3.78 (6H, s,
OMe-1, OMe-3), 5.10 (1H, m, H-14), 6.30 (1H, t, J = 2.1 Hz, H-2), 6.34
(2H, d, J = 2.1 Hz, H-4, H-6).
(R)-MTPA ester (6R). Colorless oil; Yield 88%; ESIMS: m/z = 547.3
([M + Na]+); 1H NMR (CDCl3, 300 MHz): d = 0.85 (3H, t, J = 7.2 Hz,
Me-17), 1.20 (2H, m, H2-16), 1.29 (8H, m, H2-9ꢀH2-12), 1.52 (1H, m,
Ha-15), 1.55 (1H, m, Hb-15) 1.58 (3H, m, H2-8, Ha-13), 1.63 (1H, m,
Hb-13), 2.53 (2H, t, J = 7.5 Hz, H2-7), 3.78 (6H, s, OMe-1, OMe-3), 5.10
(H, m, H-14), 6.30 (1H, t, J = 2.1 Hz, H-2), 6.34 (2H, d, J = 2.1 Hz, H-4, H-6).
OH
3
OH
MeO
O
7'
1'
15'
HO 2'
6'
OH
4'
9
OH
OH
7
S
1
3
9
10
Fig. 1. Structures of compounds 1–4 and 8–10.
5
Preparation of 2 from 1
A solution of 1 (3 mg) in acetone (3 ml) was treated with excess K2CO3,
stirred for 16 h at room temperature, filtered, and evaporated. The
residue was purified by silica gel CC to afford 2 (2.5 mg, 89%).
this order, with EtOAc and n-BuOH. The EtOAc extract was evaporated in
vacuo to give a residue (31 g), which was subjected to silica gel CC eluted
successively with petroleum ether/EtOAc (90:10, 70:30, 50:50) followed
by CHCl3/MeOH (90:10, 70:30) to give eight fractions. Fraction 6,
showing interesting red TLC spots after spraying with H2SO4, was
subjected to Sephadex LH-20 (Amersham, Biosciences, Piscataway, NJ,
USA) CC (MeOH) and silica gel (Qingdao Haiyang Chemical Co. Ltd.,
Qingdao, China) CC (eluted with CHCl3/MeOH [95:5, 90:10, 85:15,
80:20]) and then purified by Sephadex LH-20 CC (PE/CHCl3/MeOH = 2:1:1),
yielding pure compounds 1 (15.0 mg), 2 (2.3 mg), and 3 (0.5 mg).
Antitumor Bioassay
The in vitro cytotoxic activities against HepG2, NCI-H460, and
SW-1990 cell lines were investigated by using methyl-thiazol-tetrozolium
assay. Cell suspensions were seeded in 96-well plates and incubated for
8–24 h at 37 ꢂC in a 5% CO2 incubator. 10ml of the test compound solutions
(in DMSO) at various concentrations were added to each well, and the
culture was incubated for 48–96 h at 37 ꢂC in a 5% CO2 incubator. After
the treatment, 20ml of the methyl-thiazol-tetrozolium solution (5mg/ml)
was added to each well, and cells were incubated at 37ꢂ C in 5% CO2. After
incubation for 4 h, the medium was removed and 150ml of DMSO was
added. The absorbance (OD value) was measured at 550nm. Inhibition
rate= (ODcontrolꢀODcompound)/ODcontrol ꢁ 100%. Evaluation criteria were
followed by inhibition rate at reasonable concentrate: 0%–20% (invalid);
20%–50% (weak); 50%–75% (moderate); 75%–100% (potent).
Preparation of 1,3,2,4 -Tetra-O-methylintegracin A (5)
A solution of integracin A (1, 10 mg) in acetone (3 ml) was treated with
CH3I (2 ml) and excess K2CO3, stirred for 6 h at room temperature,
filtered, and evaporated. The residue was purified by silica gel CC to
afford 5 (10 mg).
1,3,2,4-Tetra-O-methylintegracin A (5). Colorless oil; Yield 92%; ESIMS:
m/z = 707 ([M + Na]+); Hydrogen-1 (1H) NMR (CDCl3, 300 MHz): d = 0.90
(3H, t, J= 7.2 Hz, Me-17), 0.94 (3H, t, J = 7.5Hz, Me-18), 1.26ꢀ1.35 (20H, m),
1.45ꢀ1.52 (8H, m), 1.56ꢀ1.63 (4H, m, H2-13, H2-15), 2.02 (3H, s, Me-200),
2.53 (4H, m, H2-7, H2-8), 3.76 (3H, s, OMe-4), 3.78 (6H, s, OMe-1, OMe-3),
3.80 (3H, s, OMe-2), 4.86 (H, m, H-15), 5.12 (H, m, H-14), 6.29 (H, d,
J= 2.1 Hz, H-3), 6.30 (H, br s, H-2), 6.32 (H, d, J= 2.1 Hz, H-5), 6.34 (2H, d,
J= 2.1 Hz, H-4, H-6).
RESULTS AND DISCUSSION
The powdered stems and leaves of S. hainanensis (2.6kg)
were extracted exhaustively with MeOH. The MeOH extract
was partitioned consecutively between EtOAc and H2O, n-
BuOH and H2O, respectively. The EtOAc-soluble portion was
subjected to CC over silica gel and Sephadex LH-20 to afford
integracins A (1, 15.0 mg), B (2, 2.3 mg), and 15-dehydroxy-
integracin B (3, 0.5 mg), respectively.
Ester Reduction of 1,3,2,4 -Tetra-O-methylintegracin A (5)
A solution of 5 (10 mg) in dry CH2Cl2 (5 ml) was treated with 0.3 ml
[(CH3)2CHCH2]2AlH (1 M in hexane), stirred for 3.5 h at ꢀ78 ꢂC. The
Chirality DOI 10.1002/chir